Irinotecan combined with leucovorin-5-fluorouracil in the treatment of advanced colorectal cancer.

被引：0
|
作者：
Rigatos, SK [1 ]
Stathopoulos, GP [1 ]
Nacos, A [1 ]
Stathopoulos, J [1 ]
Pergantas, N [1 ]
Athanassiadis, I [1 ]
机构：
[1] Univ Athens, Dept Oncol, Hippokrat Hosp, Med Div 2, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
246
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [1] Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer.
    Sargent, DJ
    Niedzwiecki, D
    O'Connell, MJ
    Schilsky, RL
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (02): : 144 - 145
  • [2] Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
    Saltz, LB
    Cox, JV
    Blanke, C
    Rosen, LS
    Fehrenbacher, L
    Moore, MJ
    Maroun, JA
    Ackland, SP
    Locker, PK
    Pirotta, N
    Elfring, GL
    Miller, LL
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13): : 905 - 914
  • [3] Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer. Reply
    Miller, LL
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (02): : 146 - 146
  • [4] Phase I and Pharmacokinetic Study of Tegafur-Uracil/Leucovorin Combined With 5-Fluorouracil/Leucovorin and Irinotecan in Patients With Advanced Colorectal Cancer
    Chayahara, Naoko
    Tamura, Takao
    Yamamori, Motohiro
    Kadowaki, Yuko
    Okuno, Tatsuya
    Miki, Ikuya
    Tsuda, Masahiro
    Nishisaki, Hogara
    Maeda, Tetsuo
    Inoue, Yoshifumi
    Okumura, Katsuhiko
    Azuma, Takeshi
    Kasuga, Masato
    Sakaeda, Toshiyuki
    Hirai, Midori
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (01): : 56 - 60
  • [5] Recent experience with oxaliplatin or irinotecan combined with S-fluorouracil and leucovorin in the treatment of colorectal cancer
    Kuebler, JP
    de Gramont, A
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 40 - 46
  • [6] Oxaliplatin, leucovorin and fluorouracil in pretreated patients with advanced colorectal cancer.
    deGramont, A
    Tournigand, C
    Louvet, C
    Andre, T
    Molitor, JL
    Raymond, E
    Moreau, S
    Vignoud, J
    LeBail, N
    Krulik, M
    REVUE DE MEDECINE INTERNE, 1997, 18 (10): : 769 - 775
  • [7] Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study
    Kalofonos, HP
    Aravantinos, G
    Kosmidis, P
    Papakostas, P
    Economopoulos, T
    Dimopoulos, M
    Skarlos, D
    Bamias, A
    Pectasides, D
    Chalkidou, S
    Karina, M
    Koutras, A
    Samantas, E
    Bacoyiannis, C
    Samelis, GF
    Basdanis, G
    Kalfarentzos, F
    Fountzilas, G
    ANNALS OF ONCOLOGY, 2005, 16 (06) : 869 - 877
  • [8] Recommendation for caution with irinotecan, fluorouracil, leucovorin for colorectal cancer
    Klautke, G
    Fietkau, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 (03) : 163 - 164
  • [9] Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
    Erlichman, C
    Goldberg, RM
    O'Connell, MJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (04): : 305 - 305
  • [10] Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
    Krieger, G
    STRAHLENTHERAPIE UND ONKOLOGIE, 2001, 177 (06) : 316 - 318
12345